The global market for Oral Delivery Vaccines was estimated to be worth US$ 2510 million in 2023 and is forecast to a readjusted size of US$ 3592.1 million by 2030 with a CAGR of 5.3% during the forecast period 2024-2030

Oral Delivery Vaccines - Market

Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

The oral vaccination market is primarily driven by the advantages it offers in terms of ease of administration, increased patient compliance, and cost-effectiveness compared to traditional injectable vaccines. Oral vaccines provide a non-invasive and painless immunization method, particularly beneficial for pediatric and elderly populations. Additionally, their potential to elicit both systemic and mucosal immunity enhances protection against pathogens that enter the body through mucosal surfaces, such as the respiratory and gastrointestinal tracts, further fueling their adoption. However, the market also faces challenges, including the complex formulation and delivery of oral vaccines, which may affect their stability and efficacy. Developing vaccines that can withstand acidic environments and enzymatic degradation in the gastrointestinal tract poses significant scientific and manufacturing challenges. Moreover, gaining regulatory approvals and ensuring public acceptance of oral vaccines may require extensive clinical data and educational efforts to dispel misconceptions about their safety and efficacy. To overcome these challenges, the industry is focused on research and innovation to improve oral vaccine formulation and delivery technologies. Collaborations between vaccine developers, research institutions, and regulatory authorities are crucial in driving the growth of the oral vaccination market and expanding access to effective and accessible immunization options, particularly in regions with limited healthcare infrastructure.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Delivery Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oral Delivery Vaccines by region & country, by Type, and by Application.

The Oral Delivery Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Delivery Vaccines.

Market Segmentation

Scope of Oral Delivery Vaccines - Market Report

Report Metric	Details
Report Name	Oral Delivery Vaccines - Market
Forecasted market size in 2030	US$ 3592.1 million
CAGR	5.3%
Forecasted years	2024 - 2030
Segment by Type:	Rotavirus Vaccine Cholera Vaccine Oral Polio Vaccine
Segment by Application	Public Private
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, Tiantan Biological, EuBiologics, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Oral Delivery Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Oral Delivery Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Oral Delivery Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Oral Delivery Vaccines - Market size in 2030?

Ans: The Oral Delivery Vaccines - Market size in 2030 will be US$ 3592.1 million.

Who are the main players in the Oral Delivery Vaccines - Market report?

Ans: The main players in the Oral Delivery Vaccines - Market are Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, Tiantan Biological, EuBiologics, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals

What are the Application segmentation covered in the Oral Delivery Vaccines - Market report?

Ans: The Applications covered in the Oral Delivery Vaccines - Market report are Public, Private

What are the Type segmentation covered in the Oral Delivery Vaccines - Market report?

Ans: The Types covered in the Oral Delivery Vaccines - Market report are Rotavirus Vaccine, Cholera Vaccine, Oral Polio Vaccine

1 Market Overview

1.1 Oral Delivery Vaccines Product Introduction

1.2 Global Oral Delivery Vaccines Market Size Forecast

1.2.1 Global Oral Delivery Vaccines Sales Value (2019-2030)

1.2.2 Global Oral Delivery Vaccines Sales Volume (2019-2030)

1.2.3 Global Oral Delivery Vaccines Sales Price (2019-2030)

1.3 Oral Delivery Vaccines Market Trends & Drivers

1.3.1 Oral Delivery Vaccines Industry Trends

1.3.2 Oral Delivery Vaccines Market Drivers & Opportunity

1.3.3 Oral Delivery Vaccines Market Challenges

1.3.4 Oral Delivery Vaccines Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Oral Delivery Vaccines Players Revenue Ranking (2023)

2.2 Global Oral Delivery Vaccines Revenue by Company (2019-2024)

2.3 Global Oral Delivery Vaccines Players Sales Volume Ranking (2023)

2.4 Global Oral Delivery Vaccines Sales Volume by Company Players (2019-2024)

2.5 Global Oral Delivery Vaccines Average Price by Company (2019-2024)

2.6 Key Manufacturers Oral Delivery Vaccines Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Oral Delivery Vaccines Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Oral Delivery Vaccines

2.9 Oral Delivery Vaccines Market Competitive Analysis

2.9.1 Oral Delivery Vaccines Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Oral Delivery Vaccines Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Delivery Vaccines as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Rotavirus Vaccine

3.1.2 Cholera Vaccine

3.1.3 Oral Polio Vaccine

3.2 Global Oral Delivery Vaccines Sales Value by Type

3.2.1 Global Oral Delivery Vaccines Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Oral Delivery Vaccines Sales Value, by Type (2019-2030)

3.2.3 Global Oral Delivery Vaccines Sales Value, by Type (%) (2019-2030)

3.3 Global Oral Delivery Vaccines Sales Volume by Type

3.3.1 Global Oral Delivery Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Oral Delivery Vaccines Sales Volume, by Type (2019-2030)

3.3.3 Global Oral Delivery Vaccines Sales Volume, by Type (%) (2019-2030)

3.4 Global Oral Delivery Vaccines Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Public

4.1.2 Private

4.2 Global Oral Delivery Vaccines Sales Value by Application

4.2.1 Global Oral Delivery Vaccines Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Oral Delivery Vaccines Sales Value, by Application (2019-2030)

4.2.3 Global Oral Delivery Vaccines Sales Value, by Application (%) (2019-2030)

4.3 Global Oral Delivery Vaccines Sales Volume by Application

4.3.1 Global Oral Delivery Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Oral Delivery Vaccines Sales Volume, by Application (2019-2030)

4.3.3 Global Oral Delivery Vaccines Sales Volume, by Application (%) (2019-2030)

4.4 Global Oral Delivery Vaccines Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Oral Delivery Vaccines Sales Value by Region

5.1.1 Global Oral Delivery Vaccines Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Oral Delivery Vaccines Sales Value by Region (2019-2024)

5.1.3 Global Oral Delivery Vaccines Sales Value by Region (2025-2030)

5.1.4 Global Oral Delivery Vaccines Sales Value by Region (%), (2019-2030)

5.2 Global Oral Delivery Vaccines Sales Volume by Region

5.2.1 Global Oral Delivery Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Oral Delivery Vaccines Sales Volume by Region (2019-2024)

5.2.3 Global Oral Delivery Vaccines Sales Volume by Region (2025-2030)

5.2.4 Global Oral Delivery Vaccines Sales Volume by Region (%), (2019-2030)

5.3 Global Oral Delivery Vaccines Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Oral Delivery Vaccines Sales Value, 2019-2030

5.4.2 North America Oral Delivery Vaccines Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Oral Delivery Vaccines Sales Value, 2019-2030

5.5.2 Europe Oral Delivery Vaccines Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Oral Delivery Vaccines Sales Value, 2019-2030

5.6.2 Asia Pacific Oral Delivery Vaccines Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Oral Delivery Vaccines Sales Value, 2019-2030

5.7.2 South America Oral Delivery Vaccines Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Oral Delivery Vaccines Sales Value, 2019-2030

5.8.2 Middle East & Africa Oral Delivery Vaccines Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Oral Delivery Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Oral Delivery Vaccines Sales Value

6.2.1 Key Countries/Regions Oral Delivery Vaccines Sales Value, 2019-2030

6.2.2 Key Countries/Regions Oral Delivery Vaccines Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Oral Delivery Vaccines Sales Value, 2019-2030

6.3.2 United States Oral Delivery Vaccines Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Oral Delivery Vaccines Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Oral Delivery Vaccines Sales Value, 2019-2030

6.4.2 Europe Oral Delivery Vaccines Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Oral Delivery Vaccines Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Oral Delivery Vaccines Sales Value, 2019-2030

6.5.2 China Oral Delivery Vaccines Sales Value by Type (%), 2023 VS 2030

6.5.3 China Oral Delivery Vaccines Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Oral Delivery Vaccines Sales Value, 2019-2030

6.6.2 Japan Oral Delivery Vaccines Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Oral Delivery Vaccines Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Oral Delivery Vaccines Sales Value, 2019-2030

6.7.2 South Korea Oral Delivery Vaccines Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Oral Delivery Vaccines Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Oral Delivery Vaccines Sales Value, 2019-2030

6.8.2 Southeast Asia Oral Delivery Vaccines Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Oral Delivery Vaccines Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Oral Delivery Vaccines Sales Value, 2019-2030

6.9.2 India Oral Delivery Vaccines Sales Value by Type (%), 2023 VS 2030

6.9.3 India Oral Delivery Vaccines Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Merck

7.1.1 Merck Company Information

7.1.2 Merck Introduction and Business Overview

7.1.3 Merck Oral Delivery Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Merck Oral Delivery Vaccines Product Offerings

7.1.5 Merck Recent Development

7.2 GSK

7.2.1 GSK Company Information

7.2.2 GSK Introduction and Business Overview

7.2.3 GSK Oral Delivery Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.2.4 GSK Oral Delivery Vaccines Product Offerings

7.2.5 GSK Recent Development

7.3 Sanofi

7.3.1 Sanofi Company Information

7.3.2 Sanofi Introduction and Business Overview

7.3.3 Sanofi Oral Delivery Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Sanofi Oral Delivery Vaccines Product Offerings

7.3.5 Sanofi Recent Development

7.4 Lanzhou Institute

7.4.1 Lanzhou Institute Company Information

7.4.2 Lanzhou Institute Introduction and Business Overview

7.4.3 Lanzhou Institute Oral Delivery Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Lanzhou Institute Oral Delivery Vaccines Product Offerings

7.4.5 Lanzhou Institute Recent Development

7.5 Serum Institute

7.5.1 Serum Institute Company Information

7.5.2 Serum Institute Introduction and Business Overview

7.5.3 Serum Institute Oral Delivery Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Serum Institute Oral Delivery Vaccines Product Offerings

7.5.5 Serum Institute Recent Development

7.6 Valneva

7.6.1 Valneva Company Information

7.6.2 Valneva Introduction and Business Overview

7.6.3 Valneva Oral Delivery Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Valneva Oral Delivery Vaccines Product Offerings

7.6.5 Valneva Recent Development

7.7 Shanghai United Cell

7.7.1 Shanghai United Cell Company Information

7.7.2 Shanghai United Cell Introduction and Business Overview

7.7.3 Shanghai United Cell Oral Delivery Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Shanghai United Cell Oral Delivery Vaccines Product Offerings

7.7.5 Shanghai United Cell Recent Development

7.8 Bibcol

7.8.1 Bibcol Company Information

7.8.2 Bibcol Introduction and Business Overview

7.8.3 Bibcol Oral Delivery Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Bibcol Oral Delivery Vaccines Product Offerings

7.8.5 Bibcol Recent Development

7.9 PaxVax

7.9.1 PaxVax Company Information

7.9.2 PaxVax Introduction and Business Overview

7.9.3 PaxVax Oral Delivery Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.9.4 PaxVax Oral Delivery Vaccines Product Offerings

7.9.5 PaxVax Recent Development

7.10 Vabiotech

7.10.1 Vabiotech Company Information

7.10.2 Vabiotech Introduction and Business Overview

7.10.3 Vabiotech Oral Delivery Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Vabiotech Oral Delivery Vaccines Product Offerings

7.10.5 Vabiotech Recent Development

7.11 Tiantan Biological

7.11.1 Tiantan Biological Company Information

7.11.2 Tiantan Biological Introduction and Business Overview

7.11.3 Tiantan Biological Oral Delivery Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Tiantan Biological Oral Delivery Vaccines Product Offerings

7.11.5 Tiantan Biological Recent Development

7.12 EuBiologics

7.12.1 EuBiologics Company Information

7.12.2 EuBiologics Introduction and Business Overview

7.12.3 EuBiologics Oral Delivery Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.12.4 EuBiologics Oral Delivery Vaccines Product Offerings

7.12.5 EuBiologics Recent Development

7.13 Panacea Biotec Ltd

7.13.1 Panacea Biotec Ltd Company Information

7.13.2 Panacea Biotec Ltd Introduction and Business Overview

7.13.3 Panacea Biotec Ltd Oral Delivery Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Panacea Biotec Ltd Oral Delivery Vaccines Product Offerings

7.13.5 Panacea Biotec Ltd Recent Development

7.14 Bio-Med

7.14.1 Bio-Med Company Information

7.14.2 Bio-Med Introduction and Business Overview

7.14.3 Bio-Med Oral Delivery Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Bio-Med Oral Delivery Vaccines Product Offerings

7.14.5 Bio-Med Recent Development

7.15 Halfkin Bio-Pharmaceuticals

7.15.1 Halfkin Bio-Pharmaceuticals Company Information

7.15.2 Halfkin Bio-Pharmaceuticals Introduction and Business Overview

7.15.3 Halfkin Bio-Pharmaceuticals Oral Delivery Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.15.4 Halfkin Bio-Pharmaceuticals Oral Delivery Vaccines Product Offerings

7.15.5 Halfkin Bio-Pharmaceuticals Recent Development

8 Industry Chain Analysis

8.1 Oral Delivery Vaccines Industrial Chain

8.2 Oral Delivery Vaccines Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Oral Delivery Vaccines Sales Model

8.5.2 Sales Channel

8.5.3 Oral Delivery Vaccines Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Halfkin Bio-Pharmaceuticals

GSK

Merck

List of Tables

Table 1. Oral Delivery Vaccines Market Trends

Table 2. Oral Delivery Vaccines Market Drivers & Opportunity

Table 3. Oral Delivery Vaccines Market Challenges

Table 4. Oral Delivery Vaccines Market Restraints

Table 5. Global Oral Delivery Vaccines Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Oral Delivery Vaccines Revenue Market Share by Company (2019-2024)

Table 7. Global Oral Delivery Vaccines Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Oral Delivery Vaccines Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Oral Delivery Vaccines Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Oral Delivery Vaccines Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Oral Delivery Vaccines Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Oral Delivery Vaccines

Table 13. Global Oral Delivery Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Delivery Vaccines as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Oral Delivery Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Oral Delivery Vaccines Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Oral Delivery Vaccines Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Oral Delivery Vaccines Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Oral Delivery Vaccines Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Oral Delivery Vaccines Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Oral Delivery Vaccines Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Oral Delivery Vaccines Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Oral Delivery Vaccines Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Oral Delivery Vaccines Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Oral Delivery Vaccines Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Oral Delivery Vaccines Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Oral Delivery Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Oral Delivery Vaccines Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Oral Delivery Vaccines Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Oral Delivery Vaccines Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Oral Delivery Vaccines Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Oral Delivery Vaccines Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Oral Delivery Vaccines Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Oral Delivery Vaccines Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Oral Delivery Vaccines Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Oral Delivery Vaccines Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Oral Delivery Vaccines Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Oral Delivery Vaccines Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Oral Delivery Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Oral Delivery Vaccines Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Oral Delivery Vaccines Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Oral Delivery Vaccines Sales Value by Region (2019-2024) & (%)

Table 44. Global Oral Delivery Vaccines Sales Value by Region (2025-2030) & (%)

Table 45. Global Oral Delivery Vaccines Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Oral Delivery Vaccines Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Oral Delivery Vaccines Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Oral Delivery Vaccines Sales Volume by Region (2019-2024) & (%)

Table 49. Global Oral Delivery Vaccines Sales Volume by Region (2025-2030) & (%)

Table 50. Global Oral Delivery Vaccines Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Oral Delivery Vaccines Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Oral Delivery Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Oral Delivery Vaccines Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Oral Delivery Vaccines Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Oral Delivery Vaccines Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Oral Delivery Vaccines Sales Volume, (2025-2030) & (K Units)

Table 57. Merck Company Information

Table 58. Merck Introduction and Business Overview

Table 59. Merck Oral Delivery Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Merck Oral Delivery Vaccines Product Offerings

Table 61. Merck Recent Development

Table 62. GSK Company Information

Table 63. GSK Introduction and Business Overview

Table 64. GSK Oral Delivery Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. GSK Oral Delivery Vaccines Product Offerings

Table 66. GSK Recent Development

Table 67. Sanofi Company Information

Table 68. Sanofi Introduction and Business Overview

Table 69. Sanofi Oral Delivery Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Sanofi Oral Delivery Vaccines Product Offerings

Table 71. Sanofi Recent Development

Table 72. Lanzhou Institute Company Information

Table 73. Lanzhou Institute Introduction and Business Overview

Table 74. Lanzhou Institute Oral Delivery Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Lanzhou Institute Oral Delivery Vaccines Product Offerings

Table 76. Lanzhou Institute Recent Development

Table 77. Serum Institute Company Information

Table 78. Serum Institute Introduction and Business Overview

Table 79. Serum Institute Oral Delivery Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Serum Institute Oral Delivery Vaccines Product Offerings

Table 81. Serum Institute Recent Development

Table 82. Valneva Company Information

Table 83. Valneva Introduction and Business Overview

Table 84. Valneva Oral Delivery Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Valneva Oral Delivery Vaccines Product Offerings

Table 86. Valneva Recent Development

Table 87. Shanghai United Cell Company Information

Table 88. Shanghai United Cell Introduction and Business Overview

Table 89. Shanghai United Cell Oral Delivery Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Shanghai United Cell Oral Delivery Vaccines Product Offerings

Table 91. Shanghai United Cell Recent Development

Table 92. Bibcol Company Information

Table 93. Bibcol Introduction and Business Overview

Table 94. Bibcol Oral Delivery Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Bibcol Oral Delivery Vaccines Product Offerings

Table 96. Bibcol Recent Development

Table 97. PaxVax Company Information

Table 98. PaxVax Introduction and Business Overview

Table 99. PaxVax Oral Delivery Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. PaxVax Oral Delivery Vaccines Product Offerings

Table 101. PaxVax Recent Development

Table 102. Vabiotech Company Information

Table 103. Vabiotech Introduction and Business Overview

Table 104. Vabiotech Oral Delivery Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Vabiotech Oral Delivery Vaccines Product Offerings

Table 106. Vabiotech Recent Development

Table 107. Tiantan Biological Company Information

Table 108. Tiantan Biological Introduction and Business Overview

Table 109. Tiantan Biological Oral Delivery Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Tiantan Biological Oral Delivery Vaccines Product Offerings

Table 111. Tiantan Biological Recent Development

Table 112. EuBiologics Company Information

Table 113. EuBiologics Introduction and Business Overview

Table 114. EuBiologics Oral Delivery Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. EuBiologics Oral Delivery Vaccines Product Offerings

Table 116. EuBiologics Recent Development

Table 117. Panacea Biotec Ltd Company Information

Table 118. Panacea Biotec Ltd Introduction and Business Overview

Table 119. Panacea Biotec Ltd Oral Delivery Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Panacea Biotec Ltd Oral Delivery Vaccines Product Offerings

Table 121. Panacea Biotec Ltd Recent Development

Table 122. Bio-Med Company Information

Table 123. Bio-Med Introduction and Business Overview

Table 124. Bio-Med Oral Delivery Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Bio-Med Oral Delivery Vaccines Product Offerings

Table 126. Bio-Med Recent Development

Table 127. Halfkin Bio-Pharmaceuticals Company Information

Table 128. Halfkin Bio-Pharmaceuticals Introduction and Business Overview

Table 129. Halfkin Bio-Pharmaceuticals Oral Delivery Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. Halfkin Bio-Pharmaceuticals Oral Delivery Vaccines Product Offerings

Table 131. Halfkin Bio-Pharmaceuticals Recent Development

Table 132. Key Raw Materials Lists

Table 133. Raw Materials Key Suppliers Lists

Table 134. Oral Delivery Vaccines Downstream Customers

Table 135. Oral Delivery Vaccines Distributors List

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. Oral Delivery Vaccines Product Picture

Figure 2. Global Oral Delivery Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Oral Delivery Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Oral Delivery Vaccines Sales Volume (2019-2030) & (K Units)

Figure 5. Global Oral Delivery Vaccines Sales Price (2019-2030) & (US$/Unit)

Figure 6. Oral Delivery Vaccines Report Years Considered

Figure 7. Global Oral Delivery Vaccines Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Oral Delivery Vaccines Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Delivery Vaccines Revenue in 2023

Figure 10. Oral Delivery Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Rotavirus Vaccine Picture

Figure 12. Cholera Vaccine Picture

Figure 13. Oral Polio Vaccine Picture

Figure 14. Global Oral Delivery Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Oral Delivery Vaccines Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Oral Delivery Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 17. Global Oral Delivery Vaccines Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Oral Delivery Vaccines Price by Type (2019-2030) & (US$/Unit)

Figure 19. Product Picture of Public

Figure 20. Product Picture of Private

Figure 21. Global Oral Delivery Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Oral Delivery Vaccines Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Oral Delivery Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Oral Delivery Vaccines Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Oral Delivery Vaccines Price by Application (2019-2030) & (US$/Unit)

Figure 26. North America Oral Delivery Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Oral Delivery Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Oral Delivery Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Oral Delivery Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Oral Delivery Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Oral Delivery Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Oral Delivery Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Oral Delivery Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Oral Delivery Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Oral Delivery Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Oral Delivery Vaccines Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Oral Delivery Vaccines Sales Volume (%), (2019-2030)

Figure 38. United States Oral Delivery Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Oral Delivery Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Oral Delivery Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Oral Delivery Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Oral Delivery Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Oral Delivery Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 44. China Oral Delivery Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Oral Delivery Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 46. China Oral Delivery Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Oral Delivery Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Oral Delivery Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Oral Delivery Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Oral Delivery Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Oral Delivery Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Oral Delivery Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Oral Delivery Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Oral Delivery Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Oral Delivery Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 56. India Oral Delivery Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Oral Delivery Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 58. India Oral Delivery Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 59. Oral Delivery Vaccines Industrial Chain

Figure 60. Oral Delivery Vaccines Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions